Medical Equipment

Antimicrobial Resistance Diagnostics Market Forecast Highlighting Growth Trends

April 9, 2026April 9, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Antimicrobial Resistance Diagnostics Market Expected To Scale Between 2026 And 2030?

The antimicrobial resistance diagnostics market has observed substantial growth in recent years. This market is projected to expand from $4.41 billion in 2025 to $4.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. Key drivers for its historical development include the increasing occurrence of antibiotic-resistant infections, the widespread use of conventional culture-based diagnostics, a surge in hospital-acquired infections, greater recognition of antimicrobial stewardship, and the establishment of more clinical microbiology laboratories.

The antimicrobial resistance diagnostics market size is projected to experience substantial growth in the upcoming years. It is anticipated to expand to $6.23 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is attributable to progress in PCR and NGS diagnostic technologies, increased government funding for AMR surveillance programs, the growing uptake of rapid diagnostic tests, the growth in pharmaceutical and biotechnology research, and the integration of data-driven decision support tools. Significant trends expected in this period include the rising adoption of rapid and point-of-care AMR diagnostics, an increasing demand for targeted and personalized antimicrobial therapy, enhanced surveillance of drug-resistant pathogens, the expansion of molecular and genomic-based diagnostic testing, and the strengthening of hospital infection control and stewardship programs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25696&type=smp

Which Primary Drivers Are Impacting The Antimicrobial Resistance Diagnostics Market Growth?

The increasing occurrence of drug-resistant infections is projected to drive the growth of the antimicrobial resistance diagnostics market in the future. Such infections arise when bacteria, viruses, fungi, or parasites evolve mechanisms to survive exposure to drugs that were previously effective against them, rendering standard therapies ineffective and making infections more difficult to manage. The growing prevalence of drug-resistant infections is attributed to the overuse of antibiotics in agriculture, where low-dose antimicrobials are routinely added to animal feed, fostering resistance that can spread to humans through the food chain. Antimicrobial resistance diagnostics, including rapid genetic assays and culture-based sensitivity tests, are crucial in combating the rising incidence of drug-resistant infections by enabling the early identification of resistant pathogens, guiding targeted treatments, and minimizing the misuse of broad-spectrum antibiotics. For instance, in November 2024, the UK Health Security Agency (UKHSA), a UK-based government agency, reported that the number of serious antibiotic-resistant infections in England increased from 58,224 in 2022 to an estimated 66,730 in 2023, while antibiotic use climbed to 2.4% in 2023 from 2022. Consequently, the rising prevalence of drug-resistant infections is propelling the expansion of the antimicrobial resistance diagnostics market.

How Is The Antimicrobial Resistance Diagnostics Market Segmented Across Different Segment Categories?

The antimicrobial resistance diagnostics market covered in this report is segmented –

1) By Product Type: Kits And Reagents, Instruments And Consumables

2) By Pathogen: Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens

3) By Technology: Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies

4) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Polymerase Chain Reaction (PCR) Reagents, Immunoassay Reagents, Stains And Dyes, Culture Media

2) By Instruments And Consumables: Polymerase Chain Reaction (PCR) Machines, Ultraviolet-Visible (UV-Vis) Spectrophotometers, Next-Generation Sequencing (NGS) Systems, Microarray Scanners, Automated Liquid Handlers, Sample Collection Tubes And Swabs

Which Trends Are Shaping Growth In The Antimicrobial Resistance Diagnostics Market?

Major companies within the antimicrobial resistance (AMR) diagnostics market are concentrating on utilizing cutting-edge technologies, such as point-of-care antimicrobial-susceptibility testing (AST) solutions, to improve diagnostic speed, accuracy, and outcomes related to antimicrobial stewardship. Point-of-care antimicrobial-susceptibility testing (AST) refers to swift, patient-side tests that identify which antibiotics will be effective against an infection, thereby assisting clinicians in quickly selecting targeted and successful treatments. For example, in June 2023, Sysmex Corporation, a Japan-based provider of in-vitro diagnostic solutions, launched the PA-100 AST System. This point-of-care rapid AST platform is designed to detect bacterial presence and determine antimicrobial susceptibility in urine samples in approximately 30 minutes. The system incorporates microfluidic single-cell analysis, offers near-patient testing, and provides automated reporting of susceptibility results. The PA-100 AST System significantly enhances clinical decision-making, helps reduce unnecessary antibiotic prescriptions, and supports timely, targeted therapy in the fight against antimicrobial resistance.

Which Organizations Play A Role In The Antimicrobial Resistance Diagnostics Market Landscape?

Major companies operating in the antimicrobial resistance diagnostics market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Becton Dickinson And Company, bioMerieux SA, Sysmex Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Seegene Inc, Alifax S r l, Accelerate Diagnostics Inc, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc, OpGen Inc, T2 Biosystems, Jiangsu Medomics Medical Technology Co Ltd, Cepheid, Luminex Corporation, Bruker Corporation, Hologic Inc

Get The Full Antimicrobial Resistance Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/antimicrobial-resistance-diagnostics-global-market-report

Which Geographic Region Dominates The Antimicrobial Resistance Diagnostics Market?

North America was the largest region in the antimicrobial resistance diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Antimicrobial Resistance Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=25696&type=smp

Browse Through More Reports Similar to the Global Antimicrobial Resistance Diagnostics Market 2026, By The Business Research Company

Sleep Apnea Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sinus Dilation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sinus-dilation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795